Form 4 Filing for ADIAL PHARMACEUTICALS, INC.

Robertson H. Gilliland, a director at ADIAL PHARMACEUTICALS, INC., was granted 9,185 restricted shares of common stock on April 7, 2026. These shares vest in full on the earlier of the one-year anniversary of the grant date or a Change of Control, provided Gilliland continues to provide services to the company. The transaction is reported on Form 4, with the signature dated April 9, 2026, indicating an attorney-in-fact for Gilliland. The shares were acquired with a reported price of $0.0, and post-transaction, Gilliland holds 9,185 shares directly.